June 24, 2026 Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
June 24, 2026 LiveOne (Nasdaq: LVO) Delivers Strong Fiscal 2026 Performance with $77.1M Revenue; Audio Division Drives Growth with $73.5M Revenue and $6.1M+ Adjusted EBITDA*; Raises Fiscal 2027 Outlook
